{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
about
MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors.The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries.Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli.GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses.Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cellsRAAS and adrenergic genes in heart failure: Function, predisposition and survival implicationsAdrenergic regulation of the rapid component of delayed rectifier K+ currents in guinea pig cardiomyocytes.Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.New Isoform of Cardiac Myosin Light Chain Kinase and the Role of Cardiac Myosin Phosphorylation in α1-Adrenoceptor Mediated Inotropic Response.The Alpha-1A Adrenergic Receptor in the Rabbit Heart.The α1A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium.Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importanceAlpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypescMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance.Adrenergic signaling in heart failure: a balance of toxic and protective effects.Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.Clinical utility of sympathetic blockade in cardiovascular disease management.Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart.An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity.Response by Simpson et al to Letter Regarding Article, "Adrenergic Receptors in Individual Ventricular Myocytes: the Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent".Role of alpha- and beta-adrenergic receptors in cardiomyocyte differentiation from murine-induced pluripotent stem cells.Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables.
P2860
Q30090168-2AE9360E-1DB6-4E2F-8065-69257C72DA66Q33613176-154F6BA8-6ACD-4E5B-B8BE-CD53662E8678Q33662261-1C3288FA-EDAA-4159-BCBB-93687DD38799Q34282113-8ACC4265-5AB8-4441-B205-5AEA093EF3D3Q34347226-B7D8329A-5078-4951-ACBD-F6D2516282A0Q34390058-39CE2F5C-3414-470D-980F-8D6E175AADF8Q34814208-C44EDC7D-2B0C-44C0-8204-A830C92BF94EQ34892203-2438649C-78AE-4404-A47F-D58F6C7288B2Q35825781-39D5BDB6-5AD3-4CAA-97C7-04F9C4374C05Q36039856-4B8F3444-5379-42B1-9592-54502D009B8AQ36114311-7C89654B-BC28-4A2B-93B9-2DC129402B70Q36201986-438B37C2-3008-49FC-BD83-4AB4167B4AC3Q36247553-63C33FB9-5F31-4B8B-BB93-28FC2ECAAB1AQ36761037-07856989-08AF-49F0-BA1D-92FDCB4DD681Q37432103-40C800B0-F2E1-4CBC-8576-1614B2D53197Q37692816-F65C9115-32A7-43AC-86A6-82D9E06863D7Q37845379-94EEC103-7052-4EE1-9CED-B8CEEC23AF54Q37956980-5BDFBB4E-C800-41EC-B980-688DBB16A2D6Q38195518-2A7FD5A8-4DE3-438D-B474-C135A718513DQ38951165-040BE006-9E52-47AE-9F31-16EF3E309C13Q39177907-AFF3FD37-0E32-4ECB-9CD6-0D5A93F57341Q39263982-E1B71F54-EF25-4268-AEBB-F33CECB8E5FAQ42070109-AF17663A-E3B3-47B8-9CC2-B3ED525A8BF2Q42317413-CB9833D0-5DAB-4E0D-A52B-E64B27E70B31Q46138504-A2A8FA67-C429-40A8-9D33-35B9FFB73112Q51358068-F9A4DE3B-4DFA-44D6-83ED-59BA3B5EAC16Q54505273-11150613-6847-460F-9A99-39D94F65117A
P2860
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
@en
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.
@nl
type
label
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
@en
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.
@nl
prefLabel
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
@en
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium.
@nl
P2093
P2860
P1476
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
@en
P2093
Brian C Jensen
Charles Hoopes
Paul C Simpson
Philip M Swigart
Teresa De Marco
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.108.846212
P577
2009-08-06T00:00:00Z